02 November 2023
02 November 2023
The transaction is anticipated to be concluded in the fourth quarter of this year.
The assets being acquired by CooperCompanies are primarily minimally invasive medical devices.
The latest models of Apple iPhones now have access to Dario Health’s smart glucose meter.
The device, which received marketing approval in China in 2021, offers users 14 days of continuous glucose monitoring without the need for frequent calibration.
The artificial intelligence driven training device, developed in collaboration with the University of Dundee, aims to improve surgical training in keyhole and laparoscopic procedures.
Embolx intends to expand access to its Sniper microcatheter across Mexico, Central America, South America and the Caribbean.
The rhCollagen-based photocurable dermal filler is developed for injection into the tissue space.
AI can “bridge the gap between human and machine”, but ensuring solid digital foundations is imperative for long-term implementation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.
Give your business an edge with our leading industry insights.
